Valeant Pharmaceuticals International, Inc. Shares Plunge After Lowered Guidance
November 08, 2016 at 10:16 AM EST
Valeant Pharmaceuticals released its latest earnings report before opening bell this morning, posting adjusted earnings of $1.55 per share on $2.48 billion in revenue.
